Physician

David E Mccune, M.D.

According to 2025 Medicare claims, David Mccune, M.D. (NPI: 1457366320) practices hematology/oncology in the Seattle-Bellevue-Kent, WA market, with the plurality of this provider's patient population coming from King, WA. This provider's primary affiliated billing organization is NORTHWEST MEDICAL SPECIALTIES PLLC (NPI: 1548261308; TIN: 911867315) and primary practice location at 98003-8707. Mccune is affiliated with the CommonSpirit ACO I (ACO ID: A2164) and Essentia Health ACO, Inc. (ACO ID: A5617), participating under the MSSP model.

Mccune's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 268 traditional Medicare patients, billed 70,808 HCPCS/CPT codes, and received $847,764 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 369 prescription claims across 82 beneficiaries totaling $709,724 in drug costs, led by Orserdu (Elacestrant Hcl). Open Payments data shows 29 records totaling $659. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $27,558 to $847,764. Similarly, Part D prescription costs have moved sharply higher in recent years, from $3,261 to $709,724. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$456K$912K2020 Medicare payment: $27,558 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $52,322 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $167,065 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $912,318 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $847,764 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20204313,433$27,558
20211018,048$52,322
202218723,302$167,065
202323582,687$912,318
202426870,808$847,764

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$355K$710K2018 Drug cost: $3,261 (USD; Tot_Drug_Cst)2019 Drug cost: $135,399 (USD; Tot_Drug_Cst)2020 Drug cost: $93,844 (USD; Tot_Drug_Cst)2021 Drug cost: $521 (USD; Tot_Drug_Cst)2022 Drug cost: $89,463 (USD; Tot_Drug_Cst)2023 Drug cost: $83,611 (USD; Tot_Drug_Cst)2024 Drug cost: $709,724 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20184091$3,261
201967224$135,399
20202665$93,844
20211526$521
202257151$89,463
202363165$83,611
202482369$709,724

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less45158$117
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more54161$100
96372Injection of drug or substance under skin or into muscle47107$12
36415Insertion of needle into vein for collection of blood sample48203$8
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count48201$7

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OrserduElacestrant Hcl11330$255,417
TagrissoOsimertinib Mesylate11330$187,235
XareltoRivaroxaban401,860$35,218
HydroxyureaHydroxyurea301,494$658
AnastrozoleAnastrozole372,820$563

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.28$659Merck Sharp & Dohme LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.1$42,153SiteSaver Inc.

FAQ

What Medicare data is available for David E. Mccune, M.D.?

Tedicare shows public-source Medicare data for David E. Mccune, M.D. (NPI 1457366320), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David E. Mccune, M.D. have ACO affiliation data?

David E. Mccune, M.D. is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164) and Essentia Health ACO, Inc. (MSSP, ACO ID A5617).

What billing organization is linked to David E. Mccune, M.D.?

David E. Mccune, M.D. is linked to NORTHWEST MEDICAL SPECIALTIES PLLC (billing NPI 1548261308) in the available physician profile data.

Does David E. Mccune, M.D. have Open Payments data?

David E. Mccune, M.D. has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.